The US Federal Trade Commission and Senator Amy Klobuchar (D-MN), head of the Senate’s Judiciary Antitrust Subcommittee, held a joint hearing to discuss pay-for-delay deals following last month’s Supreme Court decision that ruled officials can sue pharmaceutical companies for the agreements but stopped short of declaring the deals illegal. Klobuchar has introduced a bill to make the agreements illegal; the legislation is co-introduced with Senator Chuck Grassley (R-IA). The senate’s meeting wit the FTC looked to examine the deals and their effects on the pharmaceutical industry and its consumers. FTC chairwoman Edith Ramirez said at the meeting regulators will take a new, firmer stance against the settlements already litigated by the FTC and to investigate new agreements; while not all patent settlements are anticompetitive, said Ramirez, the FTC is looking to stop those that are. The watchdog says $3.5 billion in spent by consumers and the US government each year because of such deals. Ramirez did not declare, however, whether any of the current pay-for-delay cases currently under watch by the FTC will head to court.
Full Content: Reuters and Hometown Source
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI